Earnings History Data for Neuropace, Inc. (NPCE) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Neuropace, Inc.

NeuroPace Inc. is a commercial-stage medical device company. It is focused on developing products to treat and transform the lives of patients suffering from epilepsy. NeuroPace Inc. is based in MOUNTAIN VIEW, Calif.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
04-11-2025	AH		NPCE	Neuropace, Inc.	328.83	-0.11	-0.20	-0.19	NeuroPace GAAP EPS of -$0.11 beats by $0.09, revenue of $27.4M beats by $2.77M [11/4/2025 4:26 PM]	12.98	3.58 (38.09%)	11.70	2.30 (24.47%)	6.27 - 18.98	1,218,443	150,000	11,632
NeuroPace GAAP EPS of -$0.11 beats by $0.09, revenue of $27.4M beats by $2.77M [11/4/2025 4:26 PM] NeuroPace raises 2025 revenue and gross margin guidance amid record RNS growth and DIXI wind-down [11/4/2025 11:07 PM] NeuroPace Reports Third Quarter 2025 Financial Results and Increases 2025 Revenue Guidance [2025-11-04 04:05PM] NeuroPace Inc (NPCE) Q3 2025 Earnings Report Preview: What to Look For [Nov-03-25 08:04AM]
12-08-2025	AH		NPCE	Neuropace, Inc.	294.53	-0.26	-0.24	-0.26	NeuroPace GAAP EPS of -$0.26 misses by $0.04, revenue of $23.5M beats by $0.42M [8/12/2025 4:15 PM]	9.31	0.18 (1.97%)	9.00	-0.13 (-1.42%)	5.45 - 18.98	365,836	170,000	1,322
NeuroPace GAAP EPS of -$0.26 misses by $0.04, revenue of $23.5M beats by $0.42M [8/12/2025 4:15 PM] NeuroPace raises 2025 revenue guidance to $94M-$98M as RNS System drives record growth [8/12/2025 9:51 PM] Earnings To Watch: NeuroPace Inc (NPCE) Reports Q2 2025 Result [Aug-11-25 09:35AM] NeuroPace Inc (NPCE) Q2 2025 Earnings Call Highlights: Record Revenue and Strategic Growth ... [2025-08-13 03:13AM] NeuroPace Inc.: Q2 Earnings Snapshot [Aug-12-25 04:35PM]
04-03-2025	AH		NPCE	Neuropace, Inc.	374.89	-0.18	-0.25	-0.23		11.58	-0.23 (-1.95%)	11.81	0.0 (0.00%)	5.45 - 16.34	80,247	310,000	350,868

12-11-2024	AH		NPCE	Neuropace, Inc.	219.27	-0.19	-0.26	-0.28	NeuroPace GAAP EPS of -$0.19 beats by $0.08, revenue of $21.1M beats by $2.02M [11/12/2024 4:19 PM]	9.01	1.87 (26.19%)	7.14	0.0 (0.00%)	5.45 - 18.15	352,957	60,000	5,638
NeuroPace GAAP EPS of -$0.19 beats by $0.08, revenue of $21.1M beats by $2.02M [11/12/2024 4:19 PM] Earnings To Watch: NeuroPace Inc (NPCE) Reports Q3 2024 Result [Nov-11-24 07:18AM] NeuroPace Reports Third Quarter 2024 Financial Results and Increases 2024 Revenue Guidance [2024-11-12 04:05PM]
13-08-2024	AH		NPCE	NeuroPace	205.00	-0.26	-0.29	0.00	NeuroPace GAAP EPS of -$0.26 beats by $0.05, revenue of $19.3M beats by $1M [8/13/2024 4:23 PM]	6.72	-0.56 (-7.62%)	7.40	0.12 (1.64%)	4.21 - 18.15	595,253	40,000	4,964
NeuroPace GAAP EPS of -$0.26 beats by $0.05, revenue of $19.3M beats by $1M [8/13/2024 4:23 PM]
08-05-2024	AH		NPCE	Neuropace, Inc.	381.80	-0.32	-0.32	-0.41	NeuroPace GAAP EPS of -$0.32 [5/8/2024 4:28 PM]	8.00	-4.60 (-36.51%)	0.0	0.0 (0.00%)	3.80 - 18.15	418,656	80,000	0
NeuroPace GAAP EPS of -$0.32 [5/8/2024 4:28 PM]
05-03-2024	AH		NPCE	NeuroPace	425.00	-0.23	-0.33	0.00	NeuroPace GAAP EPS of -$0.23 [3/6/2024 1:11 PM]	14.04	-0.15 (-1.09%)	12.51	-1.69 (-11.90%)	3.18 - 18.15	411,900	100,000	3,470
NeuroPace GAAP EPS of -$0.23 [3/6/2024 1:11 PM]
06-11-2023	AH		NPCE	Neuropace, Inc.	181.02	-0.28	-0.39	-0.48	NeuroPace GAAP EPS of -$0.28 beats by $0.13, revenue of $16.4M beats by $2.18M [11/6/2023 4:36 PM]	7.25	0.05 (0.69%)	6.88	-0.32 (-4.44%)	1.22 - 9.73	76,846	50,000	584
NeuroPace GAAP EPS of -$0.28 beats by $0.13, revenue of $16.4M beats by $2.18M [11/6/2023 4:36 PM]
08-08-2023	AH		NPCE	Neuropace, Inc.	105.43	-0.36	-0.47	-0.52	NeuroPace GAAP EPS of -$0.36 beats by $0.11, revenue of $16.5M beats by $3.87M [8/8/2023 4:21 PM]	4.50	0.40 (9.76%)	4.60	0.50 (12.20%)	1.22 - 6.45	570,750	0	924
NeuroPace GAAP EPS of -$0.36 beats by $0.11, revenue of $16.5M beats by $3.87M [8/8/2023 4:21 PM]
04-05-2023	AH	4:00 PM ET (May 4)	NPCE	Neuropace, Inc.	123.99	-0.41	-0.46	-0.47	NeuroPace GAAP EPS of -$0.41 beats by $0.04, revenue of $14.5M beats by $2.33M [5/4/2023 5:12 PM]	5.05	0.06 (1.20%)	0.0	0.0 (0.00%)	1.22 - 7.18	64,515	20,000	0
NeuroPace GAAP EPS of -$0.41 beats by $0.04, revenue of $14.5M beats by $2.33M [5/4/2023 5:12 PM]
02-03-2023	AH	4:00 PM ET (Mar 2)	NPCE	Neuropace, Inc.	118.29	-0.45	-0.49	-0.44	NeuroPace reports Q4 results, co guides FY 2023 revenue above consensus [3/2/2023 4:08 PM]	3.90	-0.30 (-7.14%)	4.40	0.20 (4.76%)	1.22 - 9.54	143,257	30,000	310
NeuroPace reports Q4 results, co guides FY 2023 revenue above consensus [3/2/2023 4:08 PM]
08-11-2022	AH	4:00 PM ET (Nov 8)	NPCE	Neuropace, Inc.	58.64	-0.48	-0.52	-0.34	NeuroPace GAAP EPS of -$0.48 beats by $0.06, revenue of $11.2M beats by $1.31M [11/8/2022 4:12 PM]	2.19	-0.34 (-13.44%)	0.0	0.0 (0.00%)	2.12 - 17.27	53,836	10,000	0
NeuroPace GAAP EPS of -$0.48 beats by $0.06, revenue of $11.2M beats by $1.31M [11/8/2022 4:12 PM]
11-08-2022	AH	4:00 PM ET (Aug 11)	NPCE	Neuropace, Inc.	136.56	-0.52	-0.44	-0.36	NeuroPace GAAP EPS of -$0.52 misses by $0.07, revenue of $10.2M misses by $0.88M [8/11/2022 4:05 PM]	5.43	-0.45 (-7.72%)	6.14	0.25 (4.24%)	4.61 - 24.65	29,728	20,000	300
NeuroPace GAAP EPS of -$0.52 misses by $0.07, revenue of $10.2M misses by $0.88M [8/11/2022 4:05 PM] NeuroPace announces U.S. distribution agreement with DIXI Medical [8/11/2022 4:41 PM]
12-05-2022	AH	4:00 PM ET (May 12)	NPCE	Neuropace, Inc.	151.76	-0.47	-0.46	-21.21	NeuroPace GAAP EPS of -$0.47 misses by $0.04, revenue of $11.4M beats by $0.64M [5/12/2022 4:07 PM]	6.13	-0.13 (-2.08%)	6.26	0.0 (0.00%)	5.59 - 26.28	66,239	70,000	246
NeuroPace GAAP EPS of -$0.47 misses by $0.04, revenue of $11.4M beats by $0.64M [5/12/2022 4:07 PM] NeuroPace Reports First Quarter 2022 Financial Results [May-12-22 04:03PM] NeuroPace, Inc. (NPCE) Q1 2022 Earnings Call Transcript [May-13-22 04:30AM] NeuroPace to Present at the 2022 RBC Capital Markets Global Healthcare Conference [May-13-22 08:00AM] Shareholders in NeuroPace (NASDAQ:NPCE) are in the red if they invested a year ago [May-13-22 03:38PM]
10-03-2022	AH	4:00 PM ET (Mar 10)	NPCE	Neuropace, Inc.	196.94	-0.44	-0.33	0.00	NeuroPace GAAP EPS of -$0.44 misses by $0.10, revenue of $11M misses by $0.02M [3/10/2022 4:10 PM]	7.96	0.35 (4.53%)	8.55	0.40 (4.91%)	6.75 - 27.38	80,094	50,000	0
NeuroPace GAAP EPS of -$0.44 misses by $0.10, revenue of $11M misses by $0.02M [3/10/2022 4:10 PM] NeuroPace Reports Fourth Quarter & Full Year 2021 Financial Results [Mar-10-22 04:02PM] NeuroPace, Inc. (NPCE) Q4 2021 Earnings Call Transcript [Mar-10-22 08:00PM]
10-11-2021	AH	4:00 PM ET (Nov 10)	NPCE	Neuropace, Inc.	421.78	-0.34	-0.30	0.00	NeuroPace EPS misses by $0.04, misses on revenue [11/10/2021 4:07 PM]	13.89	-1.91 (-12.09%)	15.80	0.0 (0.00%)	12.00 - 27.38	173,856	50,000	100
NeuroPace gets IDE approval to initiate RNS System idiopathic generalized epilepsy study [11/10/2021 4:05 PM] NeuroPace EPS misses by $0.04, misses on revenue [11/10/2021 4:07 PM] NeurPace falls 20% after quarterly results miss estimates [11/11/2021 12:55 PM] NeuroPace Reports Third Quarter 2021 Financial Results [Nov-10-21 04:03PM] NeuroPace Receives IDE Approval to Initiate NAUTILUS Pivotal Study of its RNS System for Idiopathic Generalized Epilepsy [Nov-10-21 04:02PM] NeuroPace, Inc. (NPCE) Q3 2021 Earnings Call Transcript [Nov-11-21 10:00AM]
12-08-2021	AH	After the close (Aug 12)	NPCE	Neuropace, Inc.	580.32	-0.36	-0.39	0.00		20.40	-1.26 (-5.82%)	21.66	0.0 (0.00%)	18.24 - 27.38	170,143	20,000	534
NeuroPace Reports Second Quarter 2021 Financial Results [Aug-12-21 04:03PM] NeuroPace, Inc. (NPCE) Q2 2021 Earnings Call Transcript [Aug-13-21 08:30AM]
03-06-2021	PM	Before the open (Jun 3)	NPCE	Neuropace, Inc.	546.38	-21.21	-0.25	0.00	NeuroPace EPS misses by $32.45, beats on revenue; issues guidance [6/3/2021 7:21 AM]	21.44	-1.05 (-4.67%)	22.85	0.36 (1.60%)	18.24 - 27.38	80,779	80,000	241
NeuroPace EPS misses by $32.45, beats on revenue; issues guidance [6/3/2021 7:21 AM] NeuroPace Reports First Quarter 2021 Financial Results and Provides 2021 Financial Guidance [Jun-03-21 07:00AM] NeuroPace Inc to Host Earnings Call [Jun-03-21 06:45AM]